Managers' Transactions

Archive 2016

Managers' Transactions (Directros' dealings)

Pursuant to Art. 19 Market Abuse Regulation (EU/596/2014) ("MAR") members of the management board and supervisory board of Biotest AG, as well as any other persons performing executive functions with Biotest AG, are obliged to notify Biotest AG and the German Federal Financial Supervisory Authority (BaFin) of own transactions in Biotest shares, or financial instruments based on them. The notification duty also applies to individuals and legal entities closely associated with such persons.

In addition to all ways of publication required by law Biotest AG will disclose details of any such manager's transactions which occurred within the last twelve months on this websitewithout undue delay and will transmit to the German Federal Financial Supervisory Authority evidence of such disclosure.

Directors' Dealings in accordance with Art. 19 MAR
 Transaction:
Published 10/27/2016 LEI 529900JVX7RPXBLYUD89
Date 10/27/2016 UTC+1 Type of transaction Other
Acquisition due to a settlement of a community of heirs Testator: Dr. Hans Schleussner Heir: Dr. Cathrin Schleussner Shares: 48,135
Description of financial instrument Share ISIN DE0005227201
Place Outside a trading venue
a) Price and Volume
Price Volume
EUR 0.00 EUR 0.00
b) Aggregated information
Price Volume
EUR 0.00 EUR 0.00
 Details of person:
Name/Company Reason Initial notification / Correction
Cathrin Schleussner Member of the administrative or supervisory body
Initial notification
 Basic data:
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 
   Transaction:
Published 08/25/2016 LEI 529900JVX7RPXBLYUD89
Date 08/23/2016 UTC n/a Type of transaction Acquisition
Description of financial instrument Share ISIN DE0005227201
Place Outside a trading venue
a) Price and Volume
Price Volume
EUR 17.00 EUR 169,967.00
b) Aggregated information
Price Volume
EUR 17.00 EUR 169,967.00
 Details of person:
Name/Company Reason Initial notification / Correction
OGEL GmbH Person closely associated
Cathrin Schleussner
Initial notification
 Basic data:
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 
   Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Mar 30, 2016 Purchase Frankfurt, außerbörslich 16.6082 EUR 10000 166082
 Details of person:
Name/Company Reason Relationship
OGEL GmbH Legal person, company or institution closely associated To a person performing managerial responsibilities
 Basic data:
Description of financial instrument: Ordinary shares
ISIN DE0005227201
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 
   Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Feb 11, 2016 Purchase Frankfurt 11.474 EUR 1500 17211.00
 Details of person:
Name/Company Reason Position
Michael Dr. Ramroth
Biotest AG
Person performing managerial responsibilities Member of a managing body
 Basic data:
Description of financial instrument: Preference Shares
ISIN DE0005227235
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland